Target intelligence / Profile preview

Ovostatin 2 pseudogene (OVOS2P)

Target: OVOS2P
Molecular classification: Other (Pseudogene)

Overview

The ovostatin 2 pseudogene (OVOS2P) is a human genomic locus identified on chromosome 12, which is annotated as a non-functional pseudogene showing homology to ovostatin and alpha-2-macroglobulin-like proteins. Pseudogenes like OVOS2P do not encode functional proteins and are considered remnants of gene duplication or genomic rearrangements; thus, OVOS2P has no known molecular or clinical role, and is not regarded as a drug target or disease-associated locus. This is not a therapeutic target and should not be confused with functional serine protease inhibitors or alpha-2-macroglobulin family proteins.

Other names: DKFZp686C0338DKFZp434C0631OVOS2ovostatin homolog 2alpha-2-macroglobulin like 1 pseudogeneLOC144203

Beyond the preview

Go deeper on Ovostatin 2 pseudogene (OVOS2P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovostatin 2 pseudogene (OVOS2P).

Explore the full profile